These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 24861218)
1. Hepatitis B surface antigen positivity after twinrix vaccination: a case report. Lee Y; Kim JS; Park JY; Kim SY; Hwang IH; Cho HC J Travel Med; 2014; 21(5):352-3. PubMed ID: 24861218 [TBL] [Abstract][Full Text] [Related]
2. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule. Keystone JS; Hershey JH Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334 [TBL] [Abstract][Full Text] [Related]
3. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines. Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873 [No Abstract] [Full Text] [Related]
4. Twinrix vaccination schedules among injecting drug users. Brim N; Zaller N; Taylor LE; Feller E Expert Opin Biol Ther; 2007 Mar; 7(3):379-89. PubMed ID: 17309329 [TBL] [Abstract][Full Text] [Related]
5. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine. Van Damme P; Van Herck K Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain. Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C. Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents]. González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329 [TBL] [Abstract][Full Text] [Related]
9. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults. Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944 [TBL] [Abstract][Full Text] [Related]
10. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule. Connor BA; Blatter MM; Beran J; Zou B; Trofa AF J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248 [TBL] [Abstract][Full Text] [Related]
11. Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity. Proell S; Maiwald H; Nothdurft HD; Saenger R; Vollmar J; De Clercq N; von Sonnenburg F J Travel Med; 2002; 9(3):122-6. PubMed ID: 12088576 [TBL] [Abstract][Full Text] [Related]
12. New combined hepatitis A and B vaccine. Risks Of viral hepatitis related to travel. Zuckerman JN BMJ; 1998 Apr; 316(7140):1317. PubMed ID: 9554910 [No Abstract] [Full Text] [Related]
13. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients. Tung J; Carlisle E; Smieja M; Kim PT; Lee CH Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640 [TBL] [Abstract][Full Text] [Related]
14. [Results of Russian multicenter trial of immunogenicity, reactogenicity and safety of new combination vaccine against hepatitis A and B (Twinrix)]. Tatochenko VK; Il'ina NI; Romanenko VV; Alikova OA; Fassakhov RS; Miasnikova TN; Patlusova VV; Zima IuIu; Reshetnikova ID; Frolova GS; Smolenov IV Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):30-5. PubMed ID: 17163135 [TBL] [Abstract][Full Text] [Related]
15. New combined hepatitis A and B vaccine. New vaccine is an adjunct, not an alternative to preventive behaviours. Birthistle K; Benbow A BMJ; 1998 Apr; 316(7140):1317-8. PubMed ID: 9599053 [No Abstract] [Full Text] [Related]
16. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity. Proell S BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871 [No Abstract] [Full Text] [Related]
17. Pre-travel advice, attitudes and hepatitis A and B vaccination rates among travellers from seven countries†. Heywood AE; Nothdurft H; Tessier D; Moodley M; Rombo L; Marano C; De Moerlooze L J Travel Med; 2016 Jul; 24(1):. PubMed ID: 27738112 [TBL] [Abstract][Full Text] [Related]
18. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer. Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249 [TBL] [Abstract][Full Text] [Related]
19. New combined hepatitis A and B vaccine. Immunisation is only part of preventing infectious disease. Kasianos G BMJ; 1998 Apr; 316(7140):1317. PubMed ID: 9599052 [No Abstract] [Full Text] [Related]
20. Accelerated vaccination schedules provide protection against hepatitis A and B in last-minute travelers. Nothdurft HD; Zuckerman J; Stoffel M; Dieussaert I; Van Damme P J Travel Med; 2004; 11(4):260-1. PubMed ID: 15541232 [No Abstract] [Full Text] [Related] [Next] [New Search]